O

Onconetix Inc
D

ONCO

2.39000
USD
0.14
(6.22%)
مغلق
حجم التداول
390
الربح لكل سهم
-1
العائد الربحي
-
P/E
0
حجم السوق
3,716,474
المقالات

العنوان: Onconetix Inc

القطاع: Healthcare
الصناعة: Biotechnology
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.